BIOSAPIEN - THE REVOLUTIONARY CANCER PLATFORM DEVELOPER - ANNOUNCES TWO, WORLD-CLASS US MANUFACTURING PARTNERS: ROSWELL PARK AND BA SCIENCES

SAN DIEGO, July 1, 2026 /PRNewswire/ -- BioSapien, the pioneering biotech company, announces two world-class US manufacturing partners, ahead of imminent Phase I clinical trials for MediChip™, its revolutionary localised cancer drug delivery platform. BioSapien has been working with...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.